Quantitative evaluation of dual-channel drug supply policy on nationally negotiated anti-tumor drugs in Xuzhou: based on interrupted time series analysis
The "dual-channel" supply policy has greatly improved accessibility to anti-tumor drugs. It also reduced the financial burden of disease for ordinary residents. Therefore, we need to enhance the sufficiency of policy implementation.
Authors
- Zhaohui Qin (ORCID: https://orcid.org/0000-0001-5883-6239)
- Yanchao Xu (ORCID: https://orcid.org/0000-0002-1338-5240)
- Meng He (ORCID: https://orcid.org/0000-0003-4698-0473)
- Qi Li (ORCID: https://orcid.org/0000-0002-9422-3066)
- Min Zhou (ORCID: https://orcid.org/0000-0002-3008-4749)
- Shuo Xu
- Xueling Guan (ORCID: https://orcid.org/0000-0002-4485-6017)
Institutions
- Xuzhou Medical College (CN)
- Nantong University (CN)
- China University of Mining and Technology (CN)
- Yancheng First People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-03
- DOI
- https://doi.org/10.3389/fphar.2025.1571822
- Citations
- 1
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 3.13
Funders
- Government of Jiangsu Province